How Berkshire Hathaway’s DaVita Sale Signals Risk‑Mitigated Rebalancing and Market Trends
How Berkshire Hathaway’s 1.66‑million‑share sale of DaVita informs investors about risk, regulatory pressure, and portfolio strategy.
3 minutes to read
DaVita Inc